GoodRx Holdings, Inc. (GDRX) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Goodrx Holdings, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.496 Ladies and gentlemen, thank you for standing by and welcome to the GoodRx first quarter 00:00:04.496 -- 00:00:09.641 2025 earnings call. As a reminder, today's conference is being recorded. 00:00:09.641 -- 00:00:13.846 I would now like to introduce your host for today's call, Aubrey Reynolds, Director of 00:00:13.846 -- 00:00:16.309 Investor Relations. Ms. Reynolds, you may begin. 00:00:16.309 -- 00:00:18.030 Thank 00:00:18.030 -- 00:00:22.135 you, operator. Good morning, everyone, and welcome to GoodRx's earnings conference call 00:00:22.135 -- 00:00:24.818 for the first quarter 2025. 00:00:24.818 -- 00:00:29.044 Joining me today are Wendy Barnes, our Chief Executive Officer, and Chris McGinnis, our 00:00:29.044 -- 00:00:31.306 Chief Financial Officer. 00:00:31.306 -- 00:00:35.089 Before we begin, I'd like to remind everyone that this call will contain forward-looking 00:00:35.089 -- 00:00:36.670 statements. 00:00:36.670 -- 00:00:40.554 All statements made on this call that do not relate to matters of historical fact should 00:00:40.554 -- 00:00:45.257 be considered forward-looking statements, including, without limitation, statements regarding 00:00:45.257 -- 00:00:50.702 management's plans, strategies, goals and objectives, our market opportunity, 00:00:50.702 -- 00:00:55.486 our anticipated financial performance, underlying trends in our business and industry, 00:00:55.486 -- 00:00:59.750 including ongoing changes in the pharmacy ecosystem, and the impact of our store closures 00:00:59.750 -- 00:01:04.875 and announced bankruptcy of one of our retail partners on our business, our value proposition, 00:01:04.875 -- 00:01:10.521 our long-term growth prospects, our direct and hybrid contracting approach, 00:01:10.521 -- 00:01:14.6...